Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial.
Taniwaki M, Häner JD, Kakizaki R, Ohno Y, Yahagi K, Higuchi Y, Siontis GCM, Ando K, Stortecky S, Suzuki N, Morf L, Watanabe N, Lanz J, Ueki Y, Otsuka T, Biccirè FG, Sakurada M, Losdat S, Räber L. Taniwaki M, et al. Among authors: haner jd. Eur Heart J. 2024 Sep 1:ehae589. doi: 10.1093/eurheartj/ehae589. Online ahead of print. Eur Heart J. 2024. PMID: 39217617
Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
Rexhaj E, Bär S, Soria R, Ueki Y, Häner JD, Otsuka T, Kavaliauskaite R, Siontis GC, Stortecky S, Shibutani H, Spirk D, Engstrøm T, Lang I, Morf L, Ambühl M, Windecker S, Losdat S, Koskinas KC, Räber L; PACMAN-AMI Investigators. Rexhaj E, et al. Among authors: haner jd. Atherosclerosis. 2024 May;392:117504. doi: 10.1016/j.atherosclerosis.2024.117504. Epub 2024 Mar 6. Atherosclerosis. 2024. PMID: 38513436 Free article. Clinical Trial.
Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction: Insights From the Bern-PCI Registry.
Rohla M, Ye SX, Shibutani H, Bruno J, Otsuka T, Häner JD, Bär S, Temperli F, Kavaliauskaite R, Lanz J, Stortecky S, Praz F, Hunziker L, Pilgrim T, Siontis GC, Losdat S, Windecker S, Räber L. Rohla M, et al. Among authors: haner jd. JACC Cardiovasc Interv. 2024 Jan 8;17(1):17-28. doi: 10.1016/j.jcin.2023.10.064. JACC Cardiovasc Interv. 2024. PMID: 38199749
Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium.
Siontis GCM, Coles B, Häner JD, McGovern L, Bartkowiak J, Coughlan JJ, Spirito A, Galea R, Haeberlin A, Praz F, Tomii D, Melvin T, Frenk A, Byrne RA, Fraser AG, Windecker S; CORE-MD Investigators. Siontis GCM, et al. Among authors: haner jd. Eur Heart J. 2024 Jan 14;45(3):161-177. doi: 10.1093/eurheartj/ehad567. Eur Heart J. 2024. PMID: 37638967 Free article.
Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
Ueki Y, Häner JD, Losdat S, Gargiulo G, Shibutani H, Bär S, Otsuka T, Kavaliauskaite R, Mitter VR, Temperli F, Spirk D, Stortecky S, Siontis GCM, Valgimigli M, Windecker S, Gutmann C, Koskinas KC, Mayr M, Räber L. Ueki Y, et al. Among authors: haner jd. Thromb Haemost. 2024 Jun;124(6):517-527. doi: 10.1055/a-2156-7872. Epub 2023 Aug 18. Thromb Haemost. 2024. PMID: 37595625 Clinical Trial.
Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial.
Bär S, Kavaliauskaite R, Otsuka T, Ueki Y, Häner JD, Siontis GCM, Stortecky S, Shibutani H, Temperli F, Kaiser C, Iglesias JF, Jan van Geuns R, Daemen J, Spirk D, Engstrøm T, Lang I, Windecker S, Koskinas KC, Losdat S, Räber L. Bär S, et al. Among authors: haner jd. EuroIntervention. 2023 Jul 17;19(4):e286-e296. doi: 10.4244/EIJ-D-23-00201. EuroIntervention. 2023. PMID: 37341586 Free PMC article. Clinical Trial.
Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onset.
Rohla M, Temperli F, Siontis GCM, Klingenberg R, Gencer B, Rodondi N, Bär S, Nanchen D, Mach F, Häner JD, Pilgrim T, Muller O, Matter CM, Lüscher T, Roffi M, Heg D, Windecker S, Räber L. Rohla M, et al. Among authors: haner jd. Eur Heart J Acute Cardiovasc Care. 2023 Jun 2;12(6):376-385. doi: 10.1093/ehjacc/zuad033. Eur Heart J Acute Cardiovasc Care. 2023. PMID: 36996409 Free article.
26 results